Literature DB >> 26201953

MicroRNAs and PARP: co-conspirators with ROS in pulmonary hypertension. Focus on "miR-223 reverses experimental pulmonary arterial hypertension".

Kimberly A Smith1, Jason X-J Yuan2, Paul T Schumacker3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26201953     DOI： 10.1152/ajpcell.00209.2015

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN： 0363-6143            Impact factor:   4.249


× No keyword cloud information.
  3 in total

1.  miRNA-34a promotes proliferation of human pulmonary artery smooth muscle cells by targeting PDGFRA.

Authors:  Peng Wang; Jie Xu; Zhiling Hou; Fangfang Wang; Yingli Song; Jiao Wang; Hui Zhu; Hongbo Jin
Journal:  Cell Prolif       Date:  2016-06-15       Impact factor: 6.831

2.  Perillyle alcohol and Quercetin ameliorate monocrotaline-induced pulmonary artery hypertension in rats through PARP1-mediated miR-204 down-regulation and its downstream pathway.

Authors:  Soodeh Rajabi; Hamid Najafipour; Saeideh Jafarinejad Farsangi; Siyavash Joukar; Ahmad Beik; Maryam Iranpour; Zeinab Kordestani
Journal:  BMC Complement Med Ther       Date:  2020-07-13

Review 3.  Insights on the epigenetic mechanisms underlying pulmonary arterial hypertension.

Authors:  R C P Luna; Y de Oliveira; J V C Lisboa; T R Chaves; T A M de Araújo; E E de Sousa; M Miranda Neto; L Pirola; V A Braga; J L de Brito Alves
Journal:  Braz J Med Biol Res       Date:  2018-10-18       Impact factor: 2.590
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.